Tambong, Marilou .
HRN: 27-85-31 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2025
CEFTAZIDIME 1GM (VIAL)
09/25/2025
10/02/2025
IV
1 Gm
Q 6h
DM Foot, Right
Checking Initial Appropriateness
09/25/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/25/2025
10/02/2025
IV
600mg
Q 6h
DM Foot, Right
Checking Initial Appropriateness
10/02/2025
CLINDAMYCIN 300MG (CAP)
10/02/2025
10/09/2025
PO
300mg
TID
DM Foot
Waiting Final Action